Summary: Inspire Medical Systems has issued a recall for its Inspire IV implantable pulse generator used in treating obstructive sleep apnea due to a manufacturing defect. This defect may cause system malfunctions, including electrical leakage, potentially leading to serious … [Read more...]
Genio OSA: Nyxoah Submits Final PMA Application to FDA
Summary: Nyxoah has submitted the fourth and final module of its Premarket Approval (PMA) application to the FDA for its Genio neurostimulator, designed to treat obstructive sleep apnea (OSA). The Genio system, which is fully-body MRI-compatible and powered by a wearable, … [Read more...]
Pilot Study Reveals High Preference of Oral Appliances for OSA
Summary: Vivos Therapeutics’ pilot study showed that 79% of newly diagnosed obstructive sleep apnea (OSA) patients preferred oral appliance therapy over CPAP. The study, conducted in multiple dental and ENT offices over seven months, involved 99 patients and demonstrated high … [Read more...]
ResMed-Backed Studies at ATS 2024 Reveal Insights into OSA
Remedy of rest-disordered breathing with adaptive servo-ventilation (Browse-ASV) in opioid buyers – a European registrySunday, May possibly 19, 20249:15 AM -11:15 AM8-yr Trends in Obesity, Kind 2 Diabetes, and Glucagon-like Peptide-1 (GLP-1) Use in Patients With Obstructive … [Read more...]
Nyxoah Prepares Final FDA Module for Genio OSA Neurostimulator
Summary: Nyxoah described its Q1 2024 economic and operating outcomes, highlighting sizeable progress with its Genio program, a leadless and battery-cost-free hypoglossal neurostimulation therapy for obstructive snooze apnea (OSA). The Aspiration US pivotal study reached co-key … [Read more...]
Neurostimulator Helps Young Man with Down Syndrome and OSA
By Alyx Arnett For Amy Lopez, watching her son Nick Lopez, 20, who has Down syndrome, deal with obstructive sleep apnea (OSA) has been challenging. Diagnosed at a young age, Nick’s journey with OSA began early due to his Down syndrome-related anatomical challenges, including a … [Read more...]
ProSomnus Oral Appliance Research for OSA to be Showcased
Summary: ProSomnus Inc introduced the acceptance of two scientific abstracts for presentation at the 2024 American Academy of Dental Snooze Medication once-a-year conference. The very first analyze displays that precision oral appliance therapy substantially lowers sleep apnea … [Read more...]
LivaNova Concludes Enrollment in OSA Neurostimulator Trial
Summary: LivaNova announces completion of enrollment in the OSPREY trial for its aura6000 System, an implantable neurostimulator designed to address moderate to severe obstructive sleep apnea. The system, already CE marked, aims to maintain upper airway muscle tone, reducing or … [Read more...]
EPAP for OSA Roundtable| Sleep Review
Insights from expiratory positive airway pressure experts at BRYGGS Medical, AirAvant Medical, CPAPnea Medical Supply, and Open Airway Dental Solutions. By Lindsey Nolen Sleep Review facilitated a roundtable to examine expiratory positive airway pressure (EPAP) therapies that are … [Read more...]
4-Year-Old with Down Syndrome and OSA Benefits from Inspire
Summary: A 4-12 months-aged boy with Down syndrome and critical obstructive slumber apnea confirmed substantial advancement right after receiving a hypoglossal nerve stimulation implant, normally applied in older people and also authorised for adolescents with Down syndrome and … [Read more...]